ArticleInternational journal of cancer2025

Early pembrolizumab clearance as prognostic biomarker for non-response in patients with advanced non-small cell lung cancer.

Fenna de Vries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.